1996
DOI: 10.1111/j.1469-0691.1996.tb00559.x
|View full text |Cite
|
Sign up to set email alerts
|

In-vitro release of vancomycin and netilmicin from bone cement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1997
1997
2013
2013

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 6 publications
(5 reference statements)
0
2
0
Order By: Relevance
“…As nosocomial infections due to these organisms, notably multiply‐resistant E. faecium , increase, we can expect to encounter more enterococcal joint infections. The prevention of such infections requires a reconsideration of antibiotics for prophylaxis and in cement, as highlighted in recent correspondence [4], together with aggressive management of predisposing perioperative factors.…”
Section: Casementioning
confidence: 99%
“…As nosocomial infections due to these organisms, notably multiply‐resistant E. faecium , increase, we can expect to encounter more enterococcal joint infections. The prevention of such infections requires a reconsideration of antibiotics for prophylaxis and in cement, as highlighted in recent correspondence [4], together with aggressive management of predisposing perioperative factors.…”
Section: Casementioning
confidence: 99%
“…Thus the rate of complications is also increasing. Infection remains a serious complication [1], with current rates of infection in the primary prosthesis reported as 1.5% -2.5%, and 3.2% -5.6% after revision arthroplasty [2,3]. Nowadays, acute phase reactants such as body temperature, white blood cells (WBC), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR), which are used as systemic infection parameters, are not considered as specific markers.…”
Section: Introductionmentioning
confidence: 99%